A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...

Researchers at Oregon Health & Science University’s Knight Cancer Institute have developed a machine-learning tool that uses ...

Dr. Zhen Zeng's “MANAscore” Expedites the Effectiveness of Immunotherapy, Potentially Increasing Patient Outcomes and ...

New research defines four different immunologic subtypes of recurrent ovarian cancers and describes how those subtypes are ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an ...

These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

Several studies have now demonstrated that trained immunity occurs in the airways to several pathogens and products, while its utility is yet to be determined.

However, as the American Cancer Society (ACS) reports, “Lung cancer is by far the leading cause of cancer death in the U.S., ...

Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB ...

碱性成纤维细胞生长因子（basic fibroblast growth factor, ...

NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces that it will implement the Company’s previously disclosed plans to change the ratio of its American Depository Shares (“ADSs”) to its ...